{"id":"CHEMBL1042","canonicalSmiles":"C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C","inchiKey":"QYSXJUFSXHHAJI-YRZJJWOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLECALCIFEROL","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accrete d3","Aciferol d3","Adcal-d3","Aviticol","Bio-vitamin d3","Biolife vitamin d3","Cacit d3","Calceos","Calci-d","Calcichew d3","Calcichew d3 fte","Calcichew d3 once daily","Caldrink d3","Calfovit d3","Colecal d3","Colecalciferol","Colekal-d3","Colevit d3","Cubicole d3","D-max","D-tracetten","D-vit3","D3 lemon melts","D3-50","Dekristol","Desunin","Dihydrocholesterol","Dlux 400","E-d3","Evacal d3","Fultium daily d3","Fultium-d3","Hux d3","Invita d3","Iso d3","Kora liquid","Natecal d3","Nature's remedy vitamin d3","Neo-d","Nphd3","Osteocaps d3","Plenachol","Pro d3","Pro d3 folic","Pro d3 forte","Royalvit d3","Stexerol-d3","Stivit-d3","Sunvit-d3 1,000","Sunvit-d3 10,000","Sunvit-d3 2,000","Sunvit-d3 20,000","Sunvit-d3 3,000","Sunvit-d3 400","Sunvit-d3 5,000","Sunvit-d3 50,000","Sunvit-d3 800","Synervit-d3","Theical d-3","Thorens","Vigantol","Vigantoletten","Vigantoletten 500","Vit d3 streuli","Vita-d3","Vitamin D 3","Zymad"],"synonyms":["7-dehydrocholesterol, activated","AK R215 COMPONENT COLECALCIFEROL","AK-R215 COMPONENT COLECALCIFEROL","Cholecalciferol","Colecalciferol","Colecalciferolum","Delsterol","Delta-d","Deparal","Ebivit","NSC-375571","Provitina","Ricketon","Vitamin d","Vitamin d (cholecalciferol)","Vitamin d assay system suitability","Vitamin d-3","Vitamin d3","Vitamin d3 (as cholecalciferol)"],"crossReferences":{"DailyMed":["cholecalciferol"],"PubChem":["144205131","144209744","17388665","26754459","29215239"],"Wikipedia":["Cholecalciferol"],"drugbank":["DB00169"],"chEBI":["28940"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0000365","EFO_0000555","EFO_0000756","EFO_0003762","HP_0011950","EFO_1001951","EFO_0003964","EFO_1000653","HP_0100543","EFO_0003103","EFO_0003931","EFO_0002690","EFO_0003884","EFO_0004616","EFO_0000676","EFO_1000961","EFO_0000400","EFO_0005762","EFO_0009686","EFO_0000180","EFO_0005583","EFO_0003758","MONDO_0002363","Orphanet_636","MONDO_0002508","HP_0001742","EFO_0000384","MONDO_0008315","EFO_0000660","EFO_0002496","HP_0002027","GO_0007568","EFO_1000049","MONDO_0004979","Orphanet_101997","EFO_0000341","EFO_0007328","Orphanet_43","EFO_0003767","EFO_0004248","HP_0002901","EFO_0007405","EFO_0005878","MONDO_0007254","MONDO_0005271","Orphanet_586","EFO_0003882","MONDO_0002050","MONDO_0005180","MONDO_0002898","EFO_0000196","EFO_0002546","EFO_0000694","EFO_0000616","EFO_0000280","EFO_0000765","EFO_0004261","EFO_0008572","EFO_0003929","EFO_0000222","EFO_0000319","EFO_0001073","EFO_0000537","EFO_0000195","EFO_1001121","EFO_0000764","MONDO_0041182","EFO_0007141","MONDO_0005148","MONDO_0005178","EFO_0000519","EFO_0005411","EFO_0004265","EFO_0003956","EFO_0000729","EFO_0003095","EFO_0011057","EFO_0005406","HP_0001268","EFO_1000657","EFO_0005681","HP_0000938","EFO_0004593","EFO_0000544","Orphanet_145","MONDO_0008170","EFO_0000701","Orphanet_3389","EFO_0009516","MONDO_0044881","Orphanet_309005","HP_0002110","HP_0100806","MP_0001845","MONDO_0100096","MONDO_0021187","EFO_0008506","EFO_0000432","EFO_0000342","MONDO_0005090","Orphanet_232","EFO_0001065","EFO_0009531","EFO_0000274","MONDO_0021063","EFO_0002950","MONDO_0002146","EFO_0005531","EFO_0000474","EFO_0003144","EFO_0000673","EFO_0004272","EFO_0003047","EFO_0003917","MONDO_0004647","EFO_0008521","Orphanet_666","EFO_0007214","EFO_0002609","EFO_0000311","EFO_0003106","EFO_0003890","MONDO_0005301","EFO_0000095","EFO_0003854","MONDO_0005147","EFO_1001029","EFO_0003944","HP_0001891"],"count":130},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 96 investigational indications."}
{"id":"CHEMBL1072","canonicalSmiles":"CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1","inchiKey":"MAEIEVLCKWDQJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUMETANIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betinex","Bumetanide","Bumex","Burinex","Lixil"],"synonyms":["Bumetanide","RO 10-6338","RO-10-6338","RO-106338","S-95008.","S95008."],"crossReferences":{"DailyMed":["bumetanide"],"PubChem":["11110843","11110844","144203639","170464735","26746951","26751481","50103991","56424138","855675"],"Wikipedia":["Bumetanide"],"drugbank":["DB00887"],"chEBI":["3213"]},"linkedTargets":{"rows":["ENSG00000074803"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003756","EFO_0003144","EFO_0000182","EFO_0003884","EFO_0004255","EFO_0003758","EFO_0000373","Orphanet_681","EFO_0000319","HP_0001250","MONDO_0005148"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 5 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL107251","canonicalSmiles":"CC(=N)NCc1cccc(CN)c1","inchiKey":"RODUKNYOEVZQPR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1400W","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111967","11114075","124881823","26752186","26752187","50104843","50104844"],"drugbank":["DB02044"],"chEBI":["90721"]},"childChemblIds":["CHEMBL544788"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1078535","canonicalSmiles":"Cc1ccc2c(c1)CCCN2C(=O)SCC(=O)Nc1ccc(S(N)(=O)=O)cc1Cl","inchiKey":"AWAKIULNKVOBKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1078535","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08494"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1079175","canonicalSmiles":"NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1","inchiKey":"ULDXWLCXEDXJGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-2206","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-2206","MK2206","Mk-2206"],"crossReferences":{"PubChem":["124897541","124897542","144206919","170466896"],"chEBI":["67271"]},"childChemblIds":["CHEMBL4635254"],"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0100342","EFO_0000756","EFO_0000681","EFO_0000403","MONDO_0007254","EFO_1000657","EFO_0004252","MONDO_0021063","EFO_0000308","EFO_0000305","EFO_0003060","EFO_0001663","EFO_0000311","EFO_1000044","EFO_0006861","EFO_0000095","MONDO_0008903","EFO_0000182","MONDO_0011962","EFO_0000233","EFO_0003050","EFO_0000181"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 21 investigational indications."}
{"id":"CHEMBL109480","canonicalSmiles":"C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)NC(=CC1=O)C2=O","inchiKey":"AYUNIORJHRXIBJ-TXHRRWQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANESPIMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["17-AAG","17aag","BMS-722782","CNF-1010","CNF1010","KOS-953","NSC-330507","Tanespimycin"],"crossReferences":{"PubChem":["144205607","26756800","26756801","574817"],"Wikipedia":["Tanespimycin"],"drugbank":["DB05134"],"chEBI":["64153"]},"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0000637","MONDO_0019471","EFO_0000756","MONDO_0044887","MONDO_0007254","EFO_0000255","EFO_1001469","EFO_0000333","MONDO_0001187","EFO_1001951","EFO_0000565","EFO_0000309","MONDO_0001056","EFO_1000044","MONDO_0002225","EFO_0000389","MONDO_0008903","EFO_0000673","EFO_0000641","MONDO_0015277","EFO_0000183","EFO_1000785","EFO_0002914","EFO_0009441","EFO_0000616","MONDO_0001852","EFO_0006859","MONDO_0019465","MONDO_0008170","EFO_0000403","MONDO_0021038","MONDO_0008315","EFO_0000311","EFO_1001365","EFO_0003032","MONDO_0001023","EFO_0000095","EFO_0002428","EFO_0000574","MONDO_0002367","EFO_0000191","EFO_0001378","MONDO_0018906","EFO_1001051","EFO_1000550"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 38 investigational indications."}
{"id":"CHEMBL1112","canonicalSmiles":"O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1","inchiKey":"CEUORZQYGODEFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ARIPIPRAZOLE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abilify","Abilify maintena","Abilify maintena kit","Abilify mycite kit","Aripiprazole"],"synonyms":["Abilify mycite","Aripiprazole","Aripiprex","NSC-759266","OPC-14597","OPC-31"],"crossReferences":{"DailyMed":["aripiprazole"],"PubChem":["144205281","170465392","174006897","26719891","29215485","49666418"],"Wikipedia":["Aripiprazole"],"drugbank":["DB01238"],"chEBI":["31236"]},"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000102468"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004566","EFO_0002610","MONDO_0002009","EFO_0004216","EFO_0007453","HP_0000726","EFO_0003015","EFO_0003757","EFO_1001917","EFO_0000289","MONDO_0002050","EFO_0004714","EFO_0007319","EFO_0003761","EFO_0009854","EFO_0004701","MONDO_0007079","MONDO_0000594","EFO_0005230","EFO_0004242","EFO_0004215","EFO_0003888","EFO_0005203","EFO_0003756","EFO_0000677","EFO_0003758","EFO_1000904","EFO_0009963","EFO_0005407","EFO_0001358","EFO_0003843","Orphanet_908","HP_0000713","EFO_0008623","MONDO_0002491","EFO_0004895","MONDO_0004975","EFO_0005411"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 11 approved and 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL115220","canonicalSmiles":"O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1","inchiKey":"RIGZCVNCFXYBEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL115220","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06944"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1166","canonicalSmiles":"CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1","inchiKey":"KXNPVXPOPUZYGB-IOVMHBDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGATROBAN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acova","Argatroban","Argatroban in dextrose","Argatroban in sodium chloride"],"synonyms":["Argatroban","Argatroban anhydrous","Argatroban hydrate","Argatroban monohydrate","Argipidine","DK-7419","GN-1600","GN1600","MCI-9038","MD-805"],"crossReferences":{"DailyMed":["argatroban"],"Wikipedia":["Argatroban"],"drugbank":["DB00278"]},"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["HP_0002140","MONDO_0100096","EFO_1000985","MONDO_0000831","EFO_0001645","EFO_0000712","MONDO_0002243","EFO_0003884","EFO_0000319","HP_0004419","HP_0001873"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1185568","canonicalSmiles":"CCN1C(=CC=CC=Cc2sc3ccccc3[n+]2CC)Sc2ccccc21","inchiKey":"FYXWDSGGZAMYFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITHIAZANINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," France"],"classes":["Cardiotoxicity"," Metabolism toxicity"],"year":1964},"tradeNames":[],"synonyms":["Dithiazanine","Dithiazanine cation","Dithiazanine ion"],"crossReferences":{"PubChem":["124893646","50125814","50125815"],"drugbank":["DB11516"],"chEBI":["52787"]},"childChemblIds":["CHEMBL2357179","CHEMBL421701"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States and  France initially in 1964 due to Cardiotoxicity and  Metabolism toxicity."}
{"id":"CHEMBL1190199","canonicalSmiles":"CN(C(=O)C(c1ccccc1)c1ccccc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1","inchiKey":"JHLHNYVMZCADTC-LOSJGSFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASIMADOLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asimadoline","EMD-61753"],"crossReferences":{"Wikipedia":["Asimadoline"],"drugbank":["DB05104"]},"childChemblIds":["CHEMBL540342"],"linkedTargets":{"rows":["ENSG00000082556"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","MONDO_0004567"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1200802","canonicalSmiles":"C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O","inchiKey":"BJVVMKUXKQHWJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALBUTAL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lotusate"],"synonyms":["Talbutal"],"crossReferences":{"PubChem":["170465408"],"Wikipedia":["Talbutal"],"drugbank":["DB00306"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201","canonicalSmiles":"CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1","inchiKey":"GFBKORZTTCHDGY-UWVJOHFNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THIOTHIXENE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navane","Orbinamon","Thiothixene"],"synonyms":["(z)-thiothixene","CP-12252-1","Cis-thiothixene","NSC-108165","P-4657 B","P-4657B","Thiothixene","Thiothixene cis-isomer","Tiotixene"],"crossReferences":{"DailyMed":["thiothixene"],"PubChem":["11532885","50111253"],"Wikipedia":["Thiothixene"],"drugbank":["DB01623"]},"childChemblIds":["CHEMBL1200902","CHEMBL3989824"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005407"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for schizophrenia and psychosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201184","canonicalSmiles":"CC(=O)O.CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O","inchiKey":"DEXPIBGCLCPUHE-UISHROKMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LANREOTIDE ACETATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201185","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Somatuline depot"],"synonyms":["BIM-23014C","Lanreotide acetate","Somatuline","Somatuline lp"],"crossReferences":{"DailyMed":["lanreotide%20acetate"]},"linkedTargets":{"rows":["ENSG00000162009","ENSG00000180616"],"count":2},"linkedDiseases":{"rows":["EFO_1001485","MONDO_0024503","EFO_1000852"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for carcinoid syndrome and acromegaly and has 1 investigational indication."}
{"id":"CHEMBL1201224","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1","inchiKey":"HJJDBAOLQAWBMH-YCRCPZNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFMENOXIME","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefmenoxime","SCE-1365"],"crossReferences":{"Wikipedia":["Cefmenoxime"],"drugbank":["DB00267"],"chEBI":["55490"]},"childChemblIds":["CHEMBL3183193"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and is indicated for bacterial disease."}
{"id":"CHEMBL1201291","canonicalSmiles":"CNC(=O)c1c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NCCO)c2I)c(I)c(N(C)C(C)=O)c1I","inchiKey":"TYYBFXNZMFNZJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOXAGLIC ACID","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexabrix 320","Ioxaglate","Ioxaglic acid","P-286"],"crossReferences":{"PubChem":["11112801","144204215","56463674"],"Wikipedia":["Ioglicic_acid","Ioxaglic_acid"],"drugbank":["DB09313"],"chEBI":["31718"]},"childChemblIds":["CHEMBL1200743","CHEMBL1200508"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1201439","drugType":"Antibody","blackBoxWarning":true,"name":"BASILIXIMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Simulect"],"synonyms":["Basiliximab","CHI-621","SDZ-CHI-621"],"crossReferences":{"DailyMed":["basiliximab"],"DrugCentral":["4940"],"Wikipedia":["Basiliximab"]},"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000729","EFO_0003086","EFO_0002687","EFO_0000464","EFO_0000222","EFO_0004236","MONDO_0002462","EFO_1000794","EFO_0000540","EFO_0004599","Orphanet_567","EFO_0001422","EFO_1001231","EFO_0000544","MONDO_0005147","EFO_0003884","MONDO_0019472","EFO_1001226","EFO_0001378","EFO_0000183","MONDO_0004976","EFO_0000400","Orphanet_231214","EFO_0000519","EFO_0001062"],"count":26},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for immune system disease and has 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201533","drugType":"Protein","blackBoxWarning":false,"name":"THYROTROPIN ALFA","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thyrogen"],"synonyms":["GX-30","Thyrotropin alfa","Thyrotropin alpha"],"crossReferences":{"DailyMed":["thyrotropin%20alfa"],"DrugCentral":["4930"]},"linkedTargets":{"rows":["ENSG00000165409"],"count":1},"linkedDiseases":{"rows":["EFO_0003841","MONDO_0002108","EFO_1001062","EFO_0002892","EFO_0004237","EFO_0004705"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1201584","drugType":"Antibody","blackBoxWarning":false,"name":"ABCIXIMAB","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Reopro"],"synonyms":["Abciximab","Abciximab (genetical recombination)","C7E3"],"crossReferences":{"DrugCentral":["4950"],"Wikipedia":["Abciximab"]},"linkedTargets":{"rows":["ENSG00000259207"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0001645","EFO_0002615","EFO_1001045","EFO_0003913","EFO_0008585","EFO_1000985","EFO_0000712","MONDO_0005299","EFO_0008583","EFO_0000612","HP_0004419","HP_0031273","EFO_0005672"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for intermediate coronary syndrome and recurrent thrombophlebitis and has 7 investigational indications."}
{"id":"CHEMBL1201761","canonicalSmiles":"Cl.N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1","inchiKey":"PMQBICKXAAKXAY-HNCPQSOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BESIFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201760","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Besivance"],"synonyms":["BOL-303224-A","Besifloxacin (as hydrochloride)","Besifloxacin hcl","Besifloxacin hydrochloride","SS-734","SS734"],"crossReferences":{"DailyMed":["besifloxacin%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for bacterial conjunctivitis and has 1 investigational indication."}
{"id":"CHEMBL1201822","drugType":"Enzyme","blackBoxWarning":false,"name":"GALSULFASE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aryplase","Naglazyme"],"synonyms":["Argyplase","Arylsulfatase b galsulfase","Galsulfase","Neglazyme"],"crossReferences":{"DailyMed":["galsulfase"],"DrugCentral":["5101"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for mucopolysaccharidosis and has 1 investigational indication."}
{"id":"CHEMBL1208646","canonicalSmiles":"Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCC(=O)O","inchiKey":"HXSKWEQQPCKYIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEOPHYLLINE GLYCINATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL1200578"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL12089","canonicalSmiles":"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]","inchiKey":"VKJGBAJNNALVAV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BERBERINE CHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL295124","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berberine chloride","Berberine hydrochloride","Berberinum","GNF-Pf-4545","NSC-163088","NSC-646666"],"crossReferences":{"PubChem":["144204025","144207546","170465752","17389149","22405506","26748406","561883","56463133"],"Wikipedia":["Berberine"],"chEBI":["31271"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1213406","canonicalSmiles":"O=C1c2ccccc2C(=O)N1CCc1nnn[nH]1","inchiKey":"DEOJDUHRJBKATO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213406","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4263362"],"drugbank":["DB07055"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12198","canonicalSmiles":"CC(N)C(=O)O","inchiKey":"QNAYBMKLOCPYGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2s)-2-aminopropanoic acid","Alanine","E639","L-2-aminopropanoic acid","L-alanine","NSC-206315"],"crossReferences":{"chEBI":["16449"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1234621","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"SQVRNKJHWKZAKO-YRMXFSIDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Alpha-Sialoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Sialoside"],"crossReferences":{"Wikipedia":["Neuraminic_acid"],"drugbank":["DB03721"],"chEBI":["49026"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234750","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O","inchiKey":"KFEUJDWYNGMDBV-RCBHQUQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234750","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03618"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1254682","canonicalSmiles":"C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13","inchiKey":"OZYUPQUCAUTOBP-QXAKKESOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVALLORPHAN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levallorphan","Lorfan","Naloxiphan"],"crossReferences":{"PubChem":["144205558","170465778"],"Wikipedia":["Levallorphan"],"drugbank":["DB00504"],"chEBI":["6431"]},"childChemblIds":["CHEMBL2062276"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1256842","canonicalSmiles":"CN1Cc2c(N)cccc2C(c2ccccc2)C1.O=C(O)/C=C\\C(=O)O","inchiKey":"GEOCVSMCLVIOEV-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOMIFENSINE MALEATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL273575","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Spain"," Germany"," France"],"classes":["Hematological toxicity"," Hepatotoxicity"],"year":1986},"tradeNames":["Merital"],"synonyms":["HOE 984","HOE-984","Hostalival","NSC-289114","Nomifensine hydrogen maleate","Nomifensine maleate","Psicronizer"],"crossReferences":{"PubChem":["170466450","26747597","26747598","50106723","50106724","50106725","855660","93576623"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984. It was withdrawn in United States,  United Kingdom,  United States,  Spain,  Germany and  France initially in 1986 due to Hematological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL1276678","canonicalSmiles":"CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1","inchiKey":"NXWASIVXQMMPLM-ZXMXYHOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VTP-27999","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vtp-27999"],"crossReferences":{"drugbank":["DB12416"]},"childChemblIds":["CHEMBL2023125"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1533","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC","inchiKey":"RPLCPCMSCLEKRS-BPIQYHPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOGESTREL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aizea","Cerazette","Cerelle","Desomono","Feanolla","Nacrez","Zelleta"],"synonyms":["Desogestrel","Mircette","ORG 2969","ORG-2969"],"crossReferences":{"DailyMed":["desogestrel"],"PubChem":["144206006","50112703"],"Wikipedia":["Desogestrel"],"drugbank":["DB00304"],"chEBI":["4453"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0010269","EFO_0000545","EFO_0000731","Orphanet_661","EFO_0003894","EFO_0000660"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 4 investigational indications."}
{"id":"CHEMBL1560089","canonicalSmiles":"CN(CCO)CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C.O=C(O)c1cccnc1","inchiKey":"GEPMAHVDJHFBJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANTHINOL NIACINATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1624126","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Complamin","Complamin ret"],"synonyms":["NSC-113217","Xanthinol niacinate","Xanthinol nicotinate","Xantinol nicotinate"],"crossReferences":{"PubChem":["104171397","144204417","26757854","855806"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL15797","canonicalSmiles":"c1cnccn1","inchiKey":"KYQCOXFCLRTKLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRAZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 4015","NSC-400221","P-diazine","Piazine","Pyrazine"],"crossReferences":{"PubChem":["144210109"],"Wikipedia":["Pyrazine"],"chEBI":["30953"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1614713","canonicalSmiles":"c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1","inchiKey":"XDJCLCLBSGGNKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CC-401","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-401","Cc-401"],"crossReferences":{"drugbank":["DB12432"]},"linkedTargets":{"rows":["ENSG00000107643","ENSG00000050748","ENSG00000109339"],"count":3},"linkedDiseases":{"rows":["MONDO_0004643"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1614766","canonicalSmiles":"O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F","inchiKey":"FIMYFEGKMOCQKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RO-4987655","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CH-4987655","RO4987655","Ro 4987655","Ro-4987655"],"crossReferences":{"drugbank":["DB12933"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1615371","canonicalSmiles":"CN1c2c([nH]c(N)nc2=O)NC[C@@H]1CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Ca+2]","inchiKey":"VWBBRFHSPXRJQD-QNTKWALQSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMEFOLATE CALCIUM","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1231574","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bodyfolin","Metafolin","Nutrifolin"],"synonyms":["Calcium levomefolate","Extrafolate-s","L-5-mthf-ca","L-methylfolate-calcium","LMC-A","LMCA","Levomefolate calcium","Levomefolinate calcium","NDI 638"],"crossReferences":{"DailyMed":["levomefolate%20calcium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for acne and iron deficiency anemia."}
{"id":"CHEMBL1686","canonicalSmiles":"O=C(O)CCC(=O)C(=O)O","inchiKey":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHA-KETOGLUTARIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxoglutarate","2-Oxopentanedioic Acid","Alpha-Ketoglutarate"],"crossReferences":{"PubChem":["144208116","17389187","80706"],"Wikipedia":["Alpha-Ketoglutaric_acid"],"drugbank":["DB08845"],"chEBI":["30915"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697739","canonicalSmiles":"CCC(C(=O)O)C1(O)CCCCC1","inchiKey":"NIVFTEMPSCMWDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBUTYROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclobutyrol","JL-130"],"crossReferences":{"drugbank":["DB13493"],"chEBI":["61024"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL170","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12","inchiKey":"LOUPRKONTZGTKE-WZBLMQSHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUININE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(8s,9r)-6'-methoxycinchonan-9-ol","Chininum purum","NSC-192949","Quinine","Rezquin","WR297608"],"crossReferences":{"DailyMed":["quinine%20sulfate"],"Wikipedia":["Quinine"],"drugbank":["DB00468"],"chEBI":["15854"]},"childChemblIds":["CHEMBL1201100","CHEMBL3707252","CHEMBL2146105","CHEMBL2146083","CHEMBL3707329","CHEMBL588046","CHEMBL3229759","CHEMBL3229764","CHEMBL589001","CHEMBL1899143","CHEMBL2146084","CHEMBL2359966","CHEMBL2146088","CHEMBL3707332","CHEMBL3706390"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL17157","canonicalSmiles":"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1","inchiKey":"GUGOEEXESWIERI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERFENADINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," France"," Oman"," Saudi Arabia"],"classes":["Cardiotoxicity"],"year":1998},"tradeNames":["Antihistamine","Histafen","Histafen 120","Seldane","Terfenor","Terfenor fte","Terfex","Terfinax 120","Terfinax 60","Triludan","Triludan fte"],"synonyms":["NSC-665802","NSC-758627","RMI 9918","RMI-9918","Terfenadine"],"crossReferences":{"PubChem":["104171258","144203846","144203847","170465598","26752308","50105228","56422373","85231279","855647","90341346"],"Wikipedia":["Terfenadine"],"drugbank":["DB00342"],"chEBI":["9453"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003840","MONDO_0005301","EFO_0007425","EFO_0000403","MONDO_0005271","MONDO_0004979","EFO_0004197","EFO_0007304"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for allergic disease and has 5 investigational indications. It was withdrawn in United States,  France,  Oman and  Saudi Arabia initially in 1998 due to Cardiotoxicity."}
{"id":"CHEMBL1742983","drugType":"Antibody","blackBoxWarning":false,"name":"ALACIZUMAB PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alacizumab pegol","CDP-791","g165 DFM-PEG"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1743024","drugType":"Antibody","blackBoxWarning":false,"name":"GANITUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 479","AMG-479","AMG479","Ganitumab"],"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0003893","MONDO_0007254","EFO_0003060","EFO_0000311","EFO_1001480","EFO_1000044","EFO_0003968","EFO_0000174","EFO_0005537","EFO_0000702","EFO_0002918","EFO_0000691"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1743030","drugType":"Antibody","blackBoxWarning":false,"name":"ICRUCUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC 18F1","IMC-18F1","IMC18F1","Icrucumab"],"linkedTargets":{"rows":["ENSG00000102755"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_1000657","MONDO_0021063"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743038","drugType":"Antibody","blackBoxWarning":false,"name":"LUCATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-12.12","HCD-122","HCD122","Lucatumumab"],"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","MONDO_0018906","EFO_0000183","EFO_0005952","EFO_0001378"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1752","canonicalSmiles":"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O","inchiKey":"KSCFJBIXMNOVSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DYPHYLLINE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dilor","Dilor-400","Lufyllin","Neothylline"],"synonyms":["Diprophylline","Dyphilline","Dyphylline","Glyphylline","NSC-14305"],"crossReferences":{"PubChem":["144203995","170465316","174006928","56422180","855557"],"Wikipedia":["Dyphylline"],"drugbank":["DB00651"],"chEBI":["4728"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000172572","ENSG00000184588"],"count":5},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951 and is indicated for airway obstruction."}
{"id":"CHEMBL1823518","canonicalSmiles":"CCOC(=O)[C@H](C)NP(=O)(COCCn1cnc2c(NC3CC3)nc(N)nc21)N[C@@H](C)C(=O)OCC","inchiKey":"ANSPEDQTHURSFQ-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RABACFOSADINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9219","Rabacfosadine","VDC-1101"],"crossReferences":{"drugbank":["DB12762"]},"childChemblIds":["CHEMBL3137324"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1836264","canonicalSmiles":"O=c1oc2cc(O)ccc2c2ccc(O)cc12","inchiKey":"RIUPLDUFZCXCHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1836264","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15464"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190083","canonicalSmiles":"C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1","inchiKey":"SYTBZMRGLBWNTM-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARENFLURBIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Flurizan"],"synonyms":["E-7869","Flurbiprofen, (r)-","MPC-7869","R-flurbiprofen","Tarenflurbil"],"crossReferences":{"PubChem":["11112562","11114208","520769","520770"],"drugbank":["DB05289"],"chEBI":["38666"]},"linkedTargets":{"rows":["ENSG00000205155","ENSG00000138613","ENSG00000162736","ENSG00000080815","ENSG00000143801","ENSG00000117362"],"count":6},"linkedDiseases":{"rows":["HP_0000726","MONDO_0004975","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1908394","canonicalSmiles":"C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F","inchiKey":"ZHJGWYRLJUCMRT-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-461364","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-461364A","Gsk 461364","Gsk-461364"],"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0005952"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1950045","canonicalSmiles":"OCCc1ccc(O)c(O)c1","inchiKey":"JUUBCHWRXWPFFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4-Dihydroxyphenylethanol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Dihydroxyphenylethanol"],"crossReferences":{"drugbank":["DB12771"],"chEBI":["68889"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL196228","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@H]2O","inchiKey":"MUMGGOZAMZWBJJ-KZYORJDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPITESTOSTERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epitestosterone"],"crossReferences":{"PubChem":["144204609"],"Wikipedia":["Epitestosterone"],"drugbank":["DB07768"],"chEBI":["42534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2059028","canonicalSmiles":"COc1cc(C(=O)C(=O)N(C)[C@@H](Cc2ccc(Cl)cc2)C(=O)N(Cc2ccccc2)C(CCc2ccncc2)CCc2ccncc2)cc(OC)c1OC","inchiKey":"MQSMWZHHUGSULF-QNGWXLTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMCODAR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Timcodar","VX-853","Vx-853"],"crossReferences":{"drugbank":["DB12761"]},"childChemblIds":["CHEMBL3989889"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2103807","canonicalSmiles":"CC(C)Cn1cnc2c(N)nc3cccnc3c21","inchiKey":"UCPMSMNKGXUFCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPETIRIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["851-A","851A","Epetirimod","S-30563"],"childChemblIds":["CHEMBL2103808"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103945","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O","inchiKey":"NOENHWMKHNSHGX-IZOOSHNJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TEVERELIX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antarelix","D-23234","EP-24332","Teverelix"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105011","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C[131I])[C@H]3CC[C@@]21C","inchiKey":"FIOAEFCJGZJUPW-ODFYUTSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOCHOLESTEROL I 131","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110675","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["I-131 iodocholesterol","Iodocholesterol (131 i)","Iodocholesterol (131i)","Iodocholesterol i 131","Iodocholesterol i-131","Iodocholesterol, i-131"],"crossReferences":{"drugbank":["DB13797"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105051","canonicalSmiles":"Clc1cnn(CCCCN2CCN(c3ncccn3)CC2)c1","inchiKey":"AHCPKWJUALHOPH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LESOPITRON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lesopitron"],"crossReferences":{"drugbank":["DB04970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105753","canonicalSmiles":"CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C.Cl","inchiKey":"PKVZBNCYEICAQP-GSTSRXQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMECAMYLAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2103881","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexmecamylamine hydrochloride","NIH-11008","TC-5214"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106370","canonicalSmiles":"COc1ccnc(C[S+]([O-])c2nc3cc(-n4cccc4)ccc3[nH]2)c1C","inchiKey":"HRRXCXABAPSOCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILAPRAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ilaprazole","Noltec"],"crossReferences":{"drugbank":["DB11964"]},"linkedTargets":{"rows":["ENSG00000105675","ENSG00000186009"],"count":2},"linkedDiseases":{"rows":["EFO_0003948","MP_0001914","HP_0004398","MONDO_0001056","EFO_0004607","EFO_1000961"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107823","canonicalSmiles":"Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1","inchiKey":"SQSZANZGUXWJEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANDOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gandotinib","LY-2784544","LY2784544","Ly-2784544","Ly2784544"],"crossReferences":{"drugbank":["DB13040"]},"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107857","drugType":"Protein","blackBoxWarning":true,"name":"METRELEPTIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Leptin (human), n-methionyl-","Metreleptin","Myalept","N-methionylleptin (human)","R-METHULEPTIN"],"crossReferences":{"DailyMed":["metreleptin"],"DrugCentral":["4826"]},"linkedTargets":{"rows":["ENSG00000116678"],"count":1},"linkedDiseases":{"rows":["EFO_0000195","EFO_0010269","MONDO_0027766","MONDO_0027767","EFO_0003095","EFO_0002614","MONDO_0005147","EFO_0001421","EFO_1001348","EFO_0001073","EFO_1000727","EFO_0002756","Orphanet_98306"],"count":13},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for liver disease and lipodystrophy and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107991","drugType":"Unknown","blackBoxWarning":false,"name":"GELATIN SPONGE, ABSORBABLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spongostan","Sterispon"],"synonyms":["Absorbable gelatin sponge","Formalin treated gelatin","Gelatin sponge, absorbable","Gelatin, formalin treated","Gelfoam sponge","Surgifoam","Surgifoam sponge"],"description":"Unknown drug with a maximum clinical trial phase of IV and is indicated for hemorrhage."}
{"id":"CHEMBL2108597","drugType":"Unknown","blackBoxWarning":false,"name":"FERRIC CARBOXYMALTOSE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Injectafer"],"synonyms":["Ferric carboxymaltose","Iron dextri-maltose","VIT-45"],"crossReferences":{"DailyMed":["ferric%20carboxymaltose"],"DrugCentral":["5128"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL2109151","drugType":"Antibody","blackBoxWarning":false,"name":"LUMILIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gomiliximab","IDEC-152","Lumiliximab","P5E8 SI-3401 GOMILIXIMAB","Primatized anti-cd23","ST-152"],"linkedTargets":{"rows":["ENSG00000104921"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000095","EFO_0000574"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109463","drugType":"Antibody","blackBoxWarning":false,"name":"GSK-679586A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-679586A","Gsk-679586a"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2140408","canonicalSmiles":"Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1","inchiKey":"IVUGFMLRJOCGAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-900","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-900","AMG900","Amg 900","Amg-900"],"crossReferences":{"PubChem":["137275938"]},"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["MONDO_0004643","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2146140","canonicalSmiles":"COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.O.O.O.O.[Sr+2]","inchiKey":"NCGHIAKEJNQSMS-QLGOZJDFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESOMEPRAZOLE STRONTIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201320","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esomeprazole strontium"],"synonyms":["Esomeprazole strontium","FM-0F67","FM0F67","S-omeprazole strontium hydrate"],"crossReferences":{"DailyMed":["esomeprazole%20strontium"]},"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0009454","EFO_0004607","EFO_0007549"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved indications."}
{"id":"CHEMBL2216859","canonicalSmiles":"CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1","inchiKey":"MCIDWGZGWVSZMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEMIRALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2269557","GSK-2269557 FREE BASE","GSK-2269557A","GSK2269557A","Nemiralisib"],"childChemblIds":["CHEMBL4297193"],"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2396989","canonicalSmiles":"NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COC[C@H]2CS1","inchiKey":"NIDRNVHMMDAAIK-YPMLDQLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2886721","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2886721","Ly-2886721","Ly2886721"],"crossReferences":{"drugbank":["DB12547"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL282042","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1.CS(=O)(=O)O","inchiKey":"IRHXGOXEBNJUSN-YOXDLBRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAQUINAVIR MESYLATE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL114","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fortovase","Invirase"],"synonyms":["RO 31-8959/003","RO-318959003","Ro-31-8959-003","Saquinavir mesilate","Saquinavir mesylate","Saquinavir methanesulfonate salt"],"crossReferences":{"DailyMed":["saquinavir%20mesylate"],"PubChem":["144204688","144209731","17388741","49681831"],"chEBI":["32121"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 2 investigational indications."}
{"id":"CHEMBL296913","canonicalSmiles":"CCC(=O)[N-]S(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1.[Na+]","inchiKey":"HQPVVKXJNZEAFW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PARECOXIB SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1206690","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dynastat"],"synonyms":["Parecoxib sodium","Parecoxib sodium salt","SC-69124A"],"crossReferences":{"PubChem":["144206591"]},"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0003843","MONDO_0005178","EFO_1000635"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL299155","canonicalSmiles":"O=C(O)c1cc(=O)c2ccccc2[nH]1","inchiKey":"HCZHHEIFKROPDY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANSTORINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kynurenic Acid","Transtorine"],"crossReferences":{"PubChem":["11111352","11113415","124880498","124880499","26747099","26747100","26751656","50104346","50104347","50104348","56463252","85231101","90340624"],"Wikipedia":["Kynurenic_acid"],"drugbank":["DB11937"],"chEBI":["18344"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3121849","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3cc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc3c2)[nH]1)C(C)C","inchiKey":"LCHMHYPWGWYXEL-ZYADHFCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAVIDASVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 238630","BI-238630","C5","PPI-668 free base","Ravidasvir"],"crossReferences":{"drugbank":["DB15652"]},"childChemblIds":["CHEMBL3545312"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL316632","canonicalSmiles":"C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CCc1ccccc1","inchiKey":"ZQHYKVKNPWDQSL-KNXBSLHKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL316632","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13606"],"chEBI":["8056"]},"childChemblIds":["CHEMBL2358977"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183075","canonicalSmiles":"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1","inchiKey":"SGXXNSQHWDMGGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIZATIDINE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Axid","Axid ar","Nizatidine","Zinga 150","Zinga 300"],"synonyms":["Acinon","LY 139037","LY-139037","NSC-759289","Nizatidine"],"crossReferences":{"DailyMed":["nizatidine"],"PubChem":["144204242","144211911","170464780"],"drugbank":["DB00585"],"chEBI":["7601"]},"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["HP_0004398","EFO_0003948","MONDO_0005090","EFO_0000217","EFO_1000948","EFO_0004607","HP_0100633"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL3184512","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)N(C)C1","inchiKey":"UFUVLHLTWXBHGZ-MGZQPHGTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN PHOSPHATE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cleocin","Cleocin phosphate","Cleocin t","Clinda-derm","Clindagel","Clindamycin phosphate","Clindesse","Clindets","Dalacin","Dalacin c phos","Dalacin t","Evoclin","Zindaclin"],"synonyms":["Clindamycin 2-dihydrogen phosphate","Clindamycin phosphate","Clindamycin phosphate system suitability","NSC-618653","U 28508","U-28,508","U-28508"],"crossReferences":{"DailyMed":["clindamycin%20phosphate"],"PubChem":["144206606","144206960"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 17 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3185236","canonicalSmiles":"COc1ncc(F)c2nc(S(=O)(=O)Nc3c(F)cccc3F)nn12","inchiKey":"QZXATCCPQKOEIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORASULAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212750"],"drugbank":["DB15316"],"chEBI":["82009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186751","canonicalSmiles":"CCOc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1","inchiKey":"FFJIWWBSBCOKLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186751","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206640"],"drugbank":["DB11462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325795","canonicalSmiles":"COc1ccc([C@H]2CNC(=O)C2)cc1OC1CCCC1","inchiKey":"HJORMJIFDVBMOB-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-ROLIPRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-(+)-Rolipram"],"crossReferences":{"drugbank":["DB03606"],"chEBI":["59540"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3298910","canonicalSmiles":"CCc1nc2ccc(Cl)cn2c1C(=O)NCc1ccc(N2CCC(c3ccc(OC(F)(F)F)cc3)CC2)cc1","inchiKey":"OJICYBSWSZGRFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELACEBEC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Q-203","Q203","Telacebec"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3301572","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"NUSINERSEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BIIB-058","BIIB058","ISIS 396443","ISIS-396443","Nusinersen"],"crossReferences":{"DrugCentral":["5207"]},"linkedTargets":{"rows":["ENSG00000205571"],"count":1},"linkedDiseases":{"rows":["EFO_0008525"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3301595","canonicalSmiles":"N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21","inchiKey":"SRPXSILJHWNFMK-MEDUHNTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASOTRALINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(1r,4s)-trans-norsertraline","Dasotraline","Norsertraline, (1r,4s)-trans-","SEP-225289"],"crossReferences":{"drugbank":["DB12305"]},"childChemblIds":["CHEMBL3301596"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","MONDO_0002009"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL33845","canonicalSmiles":"Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O","inchiKey":"MDNWOSOZYLHTCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLOROPHEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anthiphen","Dichlorophen","Didroxane","G-4","NSC-38642","Parabis"],"crossReferences":{"PubChem":["144204663","144208627","144213330","170465475","17389622","26747332","26747333","26752973","50105570","56422874","8139897"],"Wikipedia":["Dichlorophene"],"drugbank":["DB11396"],"chEBI":["34689"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL35","canonicalSmiles":"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl","inchiKey":"ZZUFCTLCJUWOSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FUROSEMIDE","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aluzine 20","Aluzine 40","Aluzine 500","Aquamed","Disal","Diuresal","Dryptal","Froop","Frumax","Frumil","Frusemide","Frusetic","Frusid","Frusol","Furosemide","Hydroled","Lasix","Lasix ret","Rusyde","Tenkofruse"],"synonyms":["Frusemide","Furosemide","Furosemidum","LB-502","Logirene","Marsemide","Mirfat","NSC-269420","Oedemex"],"crossReferences":{"DailyMed":["furosemide"],"PubChem":["11112125","144203873","144209411","144213288","170464879","17389872","47193739"],"TG-GATEs":["78"],"Wikipedia":["Furosemide"],"drugbank":["DB00695"],"chEBI":["47426"]},"childChemblIds":["CHEMBL1788133"],"linkedTargets":{"rows":["ENSG00000074803"],"count":1},"linkedDiseases":{"rows":["EFO_0004610","EFO_0003086","MONDO_0005090","EFO_0000401","EFO_0009373","EFO_0000373","EFO_1002048","EFO_0009840","HP_0011950","EFO_0000565","EFO_0003914","Orphanet_70589","EFO_0003144","EFO_1001134","EFO_0003884","EFO_0004255","EFO_0003917","EFO_0000400","MONDO_0024664","HP_0002094","HP_0003124","HP_0001919","EFO_0001645","EFO_0000222","EFO_0000319","EFO_0003818","EFO_0002496","EFO_0000537","EFO_0000311","EFO_0001422","MONDO_0001134","EFO_1000391","EFO_0009662","EFO_0003827","EFO_0008583","MONDO_0005148","EFO_0000668","EFO_1000899"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and has 7 approved and 29 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL35084","canonicalSmiles":"COCCOC[C@H](CC1(C(=O)N[C@H]2CC[C@@H](C(=O)O)CC2)CCCC1)C(=O)Oc1ccc2c(c1)CCC2","inchiKey":"ZTWZVMIYIIVABD-OEMFJLHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANDOXATRIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Candoxatril","UK-79,300","UK-79300"],"crossReferences":{"PubChem":["144210768"],"drugbank":["DB00616"],"chEBI":["3353"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544988","canonicalSmiles":"O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O","inchiKey":"RUEYEZADQJCKGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPRODUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daprodustat","GSK-1278863","GSK1278863"],"crossReferences":{"drugbank":["DB11682"]},"linkedTargets":{"rows":["ENSG00000135766","ENSG00000178467","ENSG00000129521","ENSG00000269858"],"count":4},"linkedDiseases":{"rows":["EFO_0000546","EFO_0003875","EFO_0004272"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545141","drugType":"Small molecule","blackBoxWarning":false,"name":"RP-6530","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rp-6530"],"linkedTargets":{"rows":["ENSG00000171608","ENSG00000105851"],"count":2},"linkedDiseases":{"rows":["EFO_0002913","EFO_0000574"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545354","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFUSERTIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cafusertib"],"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545386","drugType":"Small molecule","blackBoxWarning":false,"name":"BI113823","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bi113823"],"linkedTargets":{"rows":["ENSG00000100739"],"count":1},"linkedDiseases":{"rows":["MONDO_0005178"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3646118","canonicalSmiles":"O=c1c(-n2ccnn2)c[nH]n1-c1cc(N2CCOCC2)ncn1","inchiKey":"IJMBOKOTALXLKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOLIDUSTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 85-3934","BAY-85-3934","Molidustat"],"crossReferences":{"drugbank":["DB15642"]},"childChemblIds":["CHEMBL3931782"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3702854","canonicalSmiles":"CC(C)(/C=C(\\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1","inchiKey":"LCFFREMLXLZNHE-GBOLQPHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILZABRUTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRN1008","Prn-1008","Prn1008","Rilzabrutinib"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0007160","EFO_0005531","MONDO_0017287","MONDO_0004979","EFO_0000274","EFO_1001264","EFO_1000749","EFO_0004719"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707389","canonicalSmiles":"NC(CCCN1C(=O)NC(c2ccccc2)(c2ccccc2)C1=O)C(=O)O","inchiKey":"PAJBBDCZSMDSFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINO(DIPHENYLHYDANTOIN) VALERIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amino(diphenylhydantoin) valeric acid"],"crossReferences":{"drugbank":["DB13396"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL375971","canonicalSmiles":"CN(C)c1ccc(/N=N/c2ccccc2C(=O)O)cc1","inchiKey":"CEQFOVLGLXCDCX-WUKNDPDISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-((4-(Dimethylamino)Phenyl)Diazenyl)Benzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-((4-(Dimethylamino)Phenyl)Diazenyl)Benzoic Acid"],"crossReferences":{"PubChem":["124898747","144211653"],"drugbank":["DB08209"],"chEBI":["49770"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833339","canonicalSmiles":"CC(C)CCON=O.CCC(C)CON=O","inchiKey":"XNCKCDBPEMSUFA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMYL NITRITE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amyl nitrite","Amyl nitrite (mixed isomers)","Amyl nitrosum","NSC-7903","Nitramyl","Nitrous acid, isopentyl ester"],"crossReferences":{"DrugCentral":["205"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3833375","canonicalSmiles":"O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]B1OB2OB([O-])OB(O1)O2","inchiKey":"CDMADVZSLOHIFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BORATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3833411","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Borax","Borax glass","Dehybor","E-285","Fused borax","Granubor","INS NO.285","INS-285","Sodium biborate","Sodium borate","Sodium borate anhydrous","Sodium borate, anhydrous","Sodium boron oxide (na2b4o7)","Sodium pyroborate","Sodium pyroborate decahydrate","Sodium tetraborate","Sodium tetraborate anhydrous","Sodium tetraborate decahydrate","Spraybor"],"crossReferences":{"DrugCentral":["4795"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833413","canonicalSmiles":"CCCCC1C(=O)N(C)N(C)C1=O.CCN(CC)CCNC(=O)COc1ccc(Cl)cc1","inchiKey":"ZMNFDNGOKBWIAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFEZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3833391"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL387262","canonicalSmiles":"N=C(N)NC(=N)SCc1cccc(C(F)(F)F)c1","inchiKey":"DWJNPCRXBNWCJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(3-Trifluoromethylphenyl)Methylamidinoisothiourea","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(3-Trifluoromethylphenyl)Methylamidinoisothiourea"],"crossReferences":{"drugbank":["DB07262"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3991065","canonicalSmiles":"C[C@@H]1[C@H](c2c(F)ccc(F)c2F)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F","inchiKey":"QIVUCLWGARAQIO-OLIXTKCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATOGEPANT","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Qulipta"],"synonyms":["AGN-241689","Atogepant","MK-8031"],"childChemblIds":["CHEMBL3981883"],"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for migraine disorder."}
{"id":"CHEMBL402315","canonicalSmiles":"C[C@H]1C[C@@H](C)CN(C(=O)c2cc(Br)ccc2NC(=O)CCC(=O)N2CCOCC2)C1","inchiKey":"DELARNBPJXTDBD-IYBDPMFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL402315","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08582"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4059888","canonicalSmiles":"Cc1cc(F)cc(C)c1C(=O)c1sc2cc(O)ccc2c1Oc1ccc(/C=C/C(=O)O)cc1","inchiKey":"KOAITBOFZOEDOC-BJMVGYQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RINTODESTRANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G1T48","GIT-48","GIT48","Rintodestrant","XR5-28"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL410668","canonicalSmiles":"CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccc2)c1","inchiKey":"OYTBZXSFNNAVKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL410668","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08242"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425646","canonicalSmiles":"N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c2ccccc12","inchiKey":"NHBIWLQQJPSMNP-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425646","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08087"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297308","canonicalSmiles":"CC(C)C[C@@H](NC(=O)[C@H](NC(=O)[C@@H](CO)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(C)O)C(C)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)O","inchiKey":"FNQVICDIQNFNHD-NBFSZNPRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"NEROFE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nerofe","Tcapf","Tumor-cells apoptosis factor"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297520","canonicalSmiles":"CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1","inchiKey":"OKFDRAHPFKMAJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OGLEMILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GRC 3845","Oglemilast"],"crossReferences":{"drugbank":["DB12375"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297569","drugType":"Unknown","blackBoxWarning":false,"name":"AVIDIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avidin","Avidin, chicken"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297641","canonicalSmiles":"C/C(=N\\NC(=O)c1cccc(S(=O)(=O)N2CCN(C)CC2)c1)c1cc(Cl)ccc1O","inchiKey":"MVSQDUZRRVBYLA-HYARGMPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SECLIDEMSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SP-2577","SP2577","Seclidemstat","Sp-2577"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297646","canonicalSmiles":"Fc1cc(F)c(OCc2ccccc2C2CCNCC2)c(F)c1","inchiKey":"TZIALEBTHQWNAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPRELOXETINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ampreloxetine","TD-9855","Td-9855"],"crossReferences":{"drugbank":["DB15348"]},"childChemblIds":["CHEMBL4594277"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_1001050","EFO_0003888","EFO_0005687","MONDO_0005180","EFO_0005252"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297651","canonicalSmiles":"CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)N1CC(CCN3CCOCC3)C1)CO2","inchiKey":"QJWJPMLDQYEPPW-AUKZVGPFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACLIMOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aclimostat","ZGN-1061","Zgn-1061"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297801","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGUNIGALSIDASE ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRX-102","Pegunigalsidase alfa","Prx-102"],"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297838","drugType":"Unknown","blackBoxWarning":false,"name":"TILSOTOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMO-2125","Tilsotolimod"],"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000756","EFO_0000311"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297976","drugType":"Enzyme","blackBoxWarning":false,"name":"N-SULFOGLUCOSAMINE SULFOHYDROLASE RECOMBINANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amidase, sulfoglucosamine sulf-","HGT-1410","Hgt-1410","N-sulfoglucosamine sulfohydrolase recombinant","Shp-610","Sulfamidase recombinant","Sulfoglucosamine sulfamidase","Sulphamidase"],"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297989","drugType":"Protein","blackBoxWarning":false,"name":"INTERLEUKIN 15, RECOMBINANT NON-GLYCOSYLATED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Il-15","Interleukin 15, recombinant non-glycosylated"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298080","drugType":"Unknown","blackBoxWarning":false,"name":"COAGULATION FACTOR IX RECOMBINANT HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coagulation factor ix recombinant human","Nonacog alfa","Nonacog gamma","Recombinant factor ix"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298101","drugType":"Antibody","blackBoxWarning":false,"name":"LADIRATUZUMAB VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ladiratuzumab vedotin","SGN-LIV1A","Sgn-liv1a"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000141424","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003968","EFO_0005537","MONDO_0007254"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL434374","canonicalSmiles":"O=C(O)CCCCCNC(=O)NC1CCCCC1","inchiKey":"KFTVEPYSUSWBRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6-(3-Cyclohexylureido)Hexanoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-(3-Cyclohexylureido)Hexanoic Acid"],"crossReferences":{"drugbank":["DB08258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL443","canonicalSmiles":"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1","inchiKey":"JLKIGFTWXXRPMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMETHOXAZOLE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetylsulfamethoxazole","Gantanol","Gantanol-ds","Sinomin","Sulfamethoxazole","Suphamethoxazole","Urobak"],"synonyms":["Acetylsulfamethoxazole","NSC-147832","RO 4-2130","RO-4-2130","STX-608","Sulfamethoxazole","Sulfamethoxazole sodium","Sulfamethoxazolum","Sulphamethoxazole"],"crossReferences":{"DailyMed":["sulfamethoxazole"],"PubChem":["11112438","124882381","144204031","144207551","170464637","17388720","49734326","855654"],"Wikipedia":["Sulfamethoxazole"],"drugbank":["DB01015"],"chEBI":["9332"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 24 investigational indications."}
{"id":"CHEMBL450044","canonicalSmiles":"CCOC(=O)OC[C@H]1O[C@@H](Oc2ccccc2Cc2ccc(OC)cc2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"QLXKHBNJTPICNF-QMCAAQAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERGLIFLOZIN ETABONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-869682X","GW-869683X","GW869682X","Sergliflozin","Sergliflozin a","Sergliflozin etabonate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL450995","canonicalSmiles":"Oc1c(Br)cc(/C=C/c2ccccc2)cc1Br","inchiKey":"WMVYUPRIADVLTH-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL450995","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08101"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4582651","canonicalSmiles":"CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1","inchiKey":"GBLBJPZSROAGMF-RWYJCYHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALSETINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gavreto"],"synonyms":["BLU-123244","BLU-667","BLU123244","Blu-667","Pralsetinib","X-581238","X581238"],"linkedTargets":{"rows":["ENSG00000165731","ENSG00000170759","ENSG00000108091"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002108","MONDO_0015277","EFO_0003060","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for non-small cell lung carcinoma and medullary thyroid gland carcinoma and has 2 investigational indications."}
{"id":"CHEMBL458402","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C","inchiKey":"YYGNTYWPHWGJRM-AAJYLUCBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUALENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206342","144206790","50125918"],"Wikipedia":["Squalene"],"drugbank":["DB11460"],"chEBI":["15440"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594354","drugType":"Unknown","blackBoxWarning":false,"name":"ALMONERTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Almonertinib","Ameile","Aumolertinib","Egfr t790m inhibitor hs-10296","HS-10296","Hs 10296","Hs-10296"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000571","MONDO_0008903","EFO_0001421","EFO_0000707","EFO_0003060","EFO_0000311"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4594460","drugType":"Unknown","blackBoxWarning":false,"name":"AT-1501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-1501","At-1501"],"linkedTargets":{"rows":["ENSG00000102245"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","MONDO_0004976","EFO_0004194"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594488","drugType":"Unknown","blackBoxWarning":false,"name":"POTASSIUM SODIUM HYDROGEN CITRATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Potassium sodium hydrogen citrate"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460499","canonicalSmiles":"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O","inchiKey":"AOCCBINRVIKJHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARMOFUR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carmofur","Mifurol","NSC-758963"],"crossReferences":{"PubChem":["144205017","170465833","174006178","26749035"],"drugbank":["DB09010"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650347","canonicalSmiles":"COCCCOc1cccc(C[S+]([O-])c2nc3cc4c(cc3[n-]2)OCC4)c1C.[Na+]","inchiKey":"LHPWFLYRYFEIBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAPRAZOLE SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4651083","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anaprazole sodium"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650496","drugType":"Unknown","blackBoxWarning":false,"name":"NM-21-1480","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NM-21-1480","NM21-1480","Nm-21-1480","Nm21-1480"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650506","drugType":"Antibody","blackBoxWarning":false,"name":"IMAPRELIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imaprelimab","PRX-003","PRX003","Prx003"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4651002","canonicalSmiles":"Cc1cn(C(=O)c2c(-c3c(Cl)cc(Cl)cc3Cl)noc2C(C)(C)F)c2cccc(/C=C/C(=O)O)c12","inchiKey":"BOOMBLZEOHXPPX-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DS-1001A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650282"],"linkedTargets":{"rows":["ENSG00000138413"],"count":1},"linkedDiseases":{"rows":["MONDO_0021639"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4802163","canonicalSmiles":"CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)C[C@@H](C(=O)N3CC(N(C)C)C3)N(C(C)C)C4)n[nH]c2c1","inchiKey":"VQIIUJSNIKEMCK-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEZULCITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nezulcitinib","TD-0903","THRX-136377","Td-0903"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL488","canonicalSmiles":"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O","inchiKey":"ROBVIMPUHSLWNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOGLUTETHIMIDE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cytadren","Orimeten"],"synonyms":["Aminoglutethimide","Cytadren","NSC-330915"],"crossReferences":{"PubChem":["144203957","144213805","170465259","174007456","26747446","459146","46500462","50105852","85230926","90340970"],"Wikipedia":["Aminoglutethimide"],"drugbank":["DB00357"],"chEBI":["2654"]},"linkedTargets":{"rows":["ENSG00000137869","ENSG00000140459"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for neoplasm and has 2 investigational indications."}
{"id":"CHEMBL492529","canonicalSmiles":"Cc1cc(Nc2ccc(C(F)(F)F)cc2)n2ncnc2n1","inchiKey":"LRHHXKBKRNNFRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DSM-74","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSM-74"],"crossReferences":{"drugbank":["DB08008"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL504","canonicalSmiles":"C[S+](C)[O-]","inchiKey":"IAZDPXIOMUYVGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYL SULFOXIDE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["DMSO","Dimethyl sulfoxide","Domoso","Infiltrina","Rimso 50","Rimso-50","Syntexan"],"synonyms":["DMSO","Dimethyl sulfoxide","NSC-763","SQ 9453","SQ-9453"],"crossReferences":{"DailyMed":["dimethyl%20sulfoxide"],"PubChem":["144211274","26757375"],"Wikipedia":["Dimethyl_sulfoxide"],"drugbank":["DB01093"],"chEBI":["28262"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL513521","canonicalSmiles":"Cl.NCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"QLSODQWNKDAMMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BL-1020","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1187646","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BL-1020","Bl-1020"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL52247","canonicalSmiles":"CNCCCC1(c2ccccc2)SC(C)(C)c2ccccc21","inchiKey":"FKHYYOUFMJBLAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALSUPRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talsupram"],"crossReferences":{"drugbank":["DB09191"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL600325","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"MYEJFUXQJGHEQK-ALRJYLEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROSCILLARIDIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Talusin","Tradenal"],"synonyms":["2936","A-32686","NSC-7521","Proscillaridin","Proscillaridin a"],"crossReferences":{"PubChem":["144203993","170465956"],"Wikipedia":["Proscillaridin"],"drugbank":["DB13307"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL600828","canonicalSmiles":"COc1c(O)ccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3","inchiKey":"UCLGCTLOEZZSLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-HYDROXY ARISTOLOCHIC A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02636"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6444","canonicalSmiles":"Cc1cc(CCCCCOc2ccc(C3=NCCO3)cc2Cl)on1","inchiKey":"FCSKOFQQCWLGMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL6444","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08719"],"chEBI":["47727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL70967","canonicalSmiles":"N#Cc1ccc(Nc2nc(N)nc(Oc3c(Cl)cccc3Cl)n2)cc1","inchiKey":"NFNNMVVXXITVGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-129385","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-129385"],"crossReferences":{"drugbank":["DB07343"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL77101","canonicalSmiles":"CCNCCCCNCCCCNCCCCNCC","inchiKey":"QXOCYGPVDXDFLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLHOMOSPERMINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethylhomospermine","NSC-741423"],"crossReferences":{"drugbank":["DB13011"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
